Floatz logo

Prevnar

Diabetes Mellitus

London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph'sDormant
D
30/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
15/ 100
Competitive Position
89/ 100

Competitive context

20 Active assets in the Diabetes Mellitus cohort.

Asset / SponsorPhaseRating
Metformin
Erbil Polytechnic University
Phase 4A
Pioglitazone
Milton S. Hershey Medical Center
Phase 4BBB
Letrozole
University of Saskatchewan
Phase 4BBB
Alogliptin
Takeda
Phase 3BBB
Glibenclamide
Takeda
Phase 4BBB

View all 50 →

Same molecule, other indications

Prevnar is also rated in:

plasma cell myelomaDormant
B
Indicative ·
56 / 100
View asset →
Multiple MyelomaDormant
CCC
Indicative ·
48 / 100
View asset →
primary peritoneal carcinomaDormant
CC
Indicative ·
43 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →